## CPRT: Copart, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 -5.8% below STRENGTH zone (4.0-10.0%); PEG 3.40 fails VALUE criteria (<1.0); RSI 28 oversold (REVERSION excluded per A/B test). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($37.00)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 1)

**1. Copart, Inc. (CPRT): A Bull Case Theory**
- Source: Insider Monkey | 20251204T121900 | Bullish | Relevance: 100%
- This article summarizes a bullish thesis on Copart, Inc. (CPRT), highlighting its strong financial performance, competitive moat, and resilient business model despite cyclical headwinds. The company reported significant net income growth, expanded margins, and increased average selling prices, reinforcing its long-term attractiveness for investors. While some AI stocks may offer higher short-term returns, Copart's fundamental strengths and strategic flexibility make a compelling bull case.

**2. Copart, Inc. $CPRT Shares Sold by Epoch Investment Partners Inc.**
- Source: MarketBeat | 20251205T101147 | Neutral | Relevance: 100%
- Epoch Investment Partners Inc. reduced its stake in Copart, Inc. (NASDAQ:CPRT) by 1.6% during the second quarter, selling 44,159 shares. Despite this, several other institutional investors increased their holdings in Copart. The article also provides details on Copart's stock performance, recent earnings, analyst ratings, and insider transactions.

**3. Baird Financial Group Inc. Sells 518,868 Shares of Copart, Inc. $CPRT**
- Source: MarketBeat | 20251205T085624 | Somewhat-Bearish | Relevance: 100%
- Baird Financial Group Inc. reduced its stake in Copart, Inc. (NASDAQ:CPRT) by 27.5% in the second quarter, selling 518,868 shares and now owning 1,371,256 shares valued at $67.29 million. Other institutional investors also adjusted their holdings, while company insiders like CEO Jeffrey Liaw and Director Thomas N. Tryforos sold significant shares. Copart's stock, currently trading at $38.80, has seen insider selling totaling over $15.8 million recently, and the company reported quarterly earnings exceeding analyst estimates.

**4. Triavera Capital LLC Has $5.56 Million Holdings in Copart, Inc. $CPRT**
- Source: MarketBeat | 20251204T140048 | Somewhat-Bearish | Relevance: 100%
- Triavera Capital LLC reduced its stake in Copart, Inc. (NASDAQ:CPRT) by 27% in Q2, now holding 113,272 shares valued at $5.56 million, constituting 2.9% of its portfolio. Insider selling activity for Copart has been significant, with insiders offloading 353,123 shares worth approximately $15.87 million in the last 90 days. Despite the insider selling and the stock trading near its 52-week low, Wall Street maintains a "Hold" rating with an average price target of $47.60.

**5. Maren Capital LLC Raises Stock Holdings in Copart, Inc. $CPRT**
- Source: MarketBeat | 20251204T122229 | Somewhat-Bullish | Relevance: 100%
- Maren Capital LLC significantly increased its stake in Copart, Inc. (NASDAQ:CPRT) by 24.7% in the second quarter, making it their 11th largest holding. Despite this institutional buying, insiders have been net sellers, offloading shares worth over $15 million in the last three months. Analysts currently have a "Hold" rating on Copart with an average price target of $47.60, as the stock trades near its 52-week low.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-24 | JP Morgan | $45 | $50 | -10% |
| 2025-11-21 | Barclays | $33 | $32 | +3% |
| 2025-11-21 | Baird | $52 | $55 | -5% |
| 2025-11-12 | Barclays | $32 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-24 | JP Morgan | main | Neutral |
| 2025-11-21 | Barclays | main | Underweight |
| 2025-11-21 | Baird | main | Outperform |
| 2025-11-12 | Barclays | init | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($0.38M) |
| Sells | 2 ($5.09M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 37.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.3% (+2.4%)
- Blackrock Inc.: 6.5% (-2.4%)
- Principal Financial : 4.2% (+3.2%)
- State Street Corpora: 3.8% (+1.8%)
- JPMORGAN CHASE & CO: 2.7% (+86.7%)

### Key Risks

1. Insider selling cluster: $5.1M in recent transactions.
2. Valuation stretched: PEG 3.4x requires aggressive growth execution.
3. Long-term trend broken: trading 22.2% below SMA200.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.40 signals overvaluation risk, limited margin of safety. Forward P/E 21.5x stretched relative to 10% growth. Quality metrics strong (ROA 11%, margin 34%). Balance sheet: strong liquidity (7.9x), low leverage (D/E 0.10). Analyst sentiment negative (2 target cuts vs 1 raises). Insider selling cluster ($5.1M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $38.0B |
| Beta | 1.12 |
| 52W Range | $38.18 - $63.85 |
| Short Interest | 3.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.40 |
| Forward P/E | 21.5 |
| Current P/E | 23.6 |
| YoY Growth | 9.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 weakening modestly (-0.8% over 5 days). Below STRENGTH zone by 9.8pp (needs >4.0% for momentum thesis). AM_20 at -3.6% indicates price below own 20MA trend. Underperforming sector by 5.0pp, stock-specific weakness. Below SMA200 (0.78x), long-term trend not supportive. RSI oversold at 28, potential bounce setup. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -5.82% (CS: 8) | Weak |
| RSI_14 | 28.5 | Oversold |
| MACD Histogram | -0.02 | Bearish |
| vs SMA20 | 0.964x | Below |
| vs SMA50 | 0.911x | Below |
| vs SMA200 | 0.778x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $38.72
- **Stop Loss:** $37.00 (4.4% risk)
- **Target:** $40.44 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 697
- **Position Value:** $26,987.84
- **Portfolio %:** 26.99%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-19 (Est: $0.39)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.39 | $0.41 | +5.1% |
| 2025Q3 | $0.36 | $0.41 | +13.3% |
| 2025Q2 | $0.42 | $0.42 | +0.8% |
| 2025Q1 | $0.37 | $0.40 | +7.5% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*